Drugs / DA-5223-R
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07633691 | Jun 2026 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT07007533 | Jul 2025 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5223-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07633691 ↗ |